非处方抗生素损害氨基糖苷类活性
该体外研究将细菌病原体暴露于氨基糖苷类杀菌浓度下,同时加入含杆菌肽、短杆菌肽或酪丝菌素的使用浓度,用时间-杀菌试验检测非处方咽喉药物中三种抗生素对氨基糖苷类活性的影响。结果显示短杆菌肽(15 µg/mL)显著降低阿米卡星、妥布霉素或庆大霉素对鲍曼不动杆菌的杀菌活性,并降低庆大霉素对阴沟肠杆菌、大肠埃希菌和肺炎克雷伯菌的活性。作者认为部分非处方抗生素可干扰氨基糖苷类活性,从而可能影响疗效并促进耐药发展。
要点
- 短杆菌肽(15 µg/mL)显著降低阿米卡星、妥布霉素或庆大霉素对鲍曼不动杆菌的杀菌活性。
- 短杆菌肽降低庆大霉素对阴沟肠杆菌、大肠埃希菌和肺炎克雷伯菌的活性。
- 酪丝菌素降低氨基糖苷类对阴沟肠杆菌和大肠埃希菌的疗效。
核心结论
- 短杆菌肽以及在一定程度上酪丝菌素通过影响膜电位(氨基糖苷类摄取所必需)而影响氨基糖苷类疗效。
- 部分非处方抗生素可干扰氨基糖苷类活性,进而可能影响治疗疗效。
- 尽管非处方抗生素与氨基糖苷类同时使用的可能性可能不常见,本研究突显了非处方抗生素使用导致治疗失败的一个潜在原因及其对耐药发展的贡献。
研究设计与样本
- 体外研究:将细菌病原体暴露于氨基糖苷类杀菌浓度,同时加入或不加入杆菌肽、短杆菌肽或酪丝菌素的使用浓度,进行时间-杀菌试验。
- 通过测定非处方抗生素暴露后的钾泄漏和膜电位改变来研究细菌膜损伤。
主要发现
- 短杆菌肽(15 µg/mL)显著降低阿米卡星、妥布霉素或庆大霉素对鲍曼不动杆菌的杀菌活性。
- 短杆菌肽降低庆大霉素对阴沟肠杆菌、大肠埃希菌和肺炎克雷伯菌的杀菌活性。
- 酪丝菌素降低氨基糖苷类对阴沟肠杆菌和大肠埃希菌的疗效。
- 短杆菌肽显著降低细菌膜电位并引起显著钾泄漏。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Antimicrobial resistance (AMR) is a global issue that needs addressing. While antibiotic stewardship has improved often by restricting antibiotic use, some antibiotics that are still sold legally over the counter (OTC), notably in sore throat medications. Recent findings suggest OTC antibiotics could trigger cross-resistance to antibiotics used in clinical treatments, whether systemic or topical. Here we investigated the impact of three antibiotics contained in OTC sore throat medicines on emerging AMR in vitro. METHODS: Bacterial pathogens were exposed to a bactericidal concentration of an aminoglycoside in the presence or absence of a during-use concentration of bacitracin, gramicidin or tyrothricin in a time-kill assay. Damage to the bacterial membrane was also investigated by measuring potassium leakage and membrane potential alteration post-OTC antibiotic exposure. RESULTS: Gramicidin (15 µg/mL) significantly decreased the bactericidal activity of amikacin, tobramycin or gentamicin in Acinetobacter baumannii. It also decreased gentamicin bactericidal activity in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae, while tyrothricin decreased the aminoglycoside efficacy in E. cloacae and E. coli. Gramicidin significantly decreased bacterial membrane potential and caused significant potassium leakage. CONCLUSION: Gramicidin and to some extent tyrothricin impacted aminoglycoside efficacy by affecting membrane potential, which is essential for aminoglycosides uptake. Thus, some OTC antibiotics can interfere with aminoglycoside activity, which could in turn affect treatment efficacy. Although the likelihood of OTC antibiotics and aminoglycosides being used at the same time might not be common, this research highlights one potential reason for OTC antibiotics' usage to result in treatment failure and their contribution to AMR development.
引用
- Robertson A, Coutinho G, Mantzourani E, et al. Over-the-counter antibiotics compromising aminoglycoside activity. J Antimicrob Chemother. 2025. PMID: 39471310. doi:10.1093/jac/dkae376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。